Anna Chérouvrier Hansson, Henrik Appelgren
Anna Chérouvrier Hansson is joining SenzaGen as the firm's chief commercial officer, and Henrik Appelgren will become its chief scientific officer. The firm said that the appointments are the final steps as it prepares to commercialize its GARD tests and to list on the Nasdaq First North. Hansson most recently was the director of marketing at Camurus. She begins her new job on Aug. 15. Appelgren has been with the Swedish Chemicals Agency for 15 years, where he was Sweden's national coordinator in the OECD Test Guideline Programme. He joins SenzaGen on Sept. 4.